Alpha-2A Adrenergic Receptor (ADRA2A) Peptide
ADRA2A
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits ADRA2A
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Origine
- Humain, Souris
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- ADRA2A peptide corresponds to 13 amino acids of ADRA2A.
-
-
- Indications d'application
- ADRA2A Peptide is used for blocking the activity of ADRA2A antibody . The ADRA2A antibody ships at 0.5 mg/mL and the ADRA2A Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- ADRA2A peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Synonymes
- ADRA2A Peptide, AW122659 Peptide, Adra-2 Peptide, Adra-2a Peptide, alpha(2A)AR Peptide, alpha2-C10 Peptide, alpha2A Peptide, alpha2A-AR Peptide, ADRA2 Peptide, ADRA2R Peptide, ADRAR Peptide, ALPHA2AAR Peptide, ZNF32 Peptide, CA2-47 Peptide, RATRG20 Peptide, RG20 Peptide, PORA2AR Peptide, adrenoceptor alpha 2A Peptide, alpha-2A adrenergic receptor-like Peptide, adrenergic receptor, alpha 2a Peptide, adra2a Peptide, ADRA2A Peptide, LOC100414445 Peptide, Adra2a Peptide
- ID gène
- 150
- NCBI Accession
- NP_000672
- OMIM
- 194353970
- UniProt
- P08913
-
Vous êtes ici:
